The mission of the company is to develop innovative diagnostic reagents, cellular therapeutics technologies and engineered cell products to help cure human diseases, including cancer, autoimmune disease, virus-infection diseases and aging.

STΦ Therapeutics is Fred Hutchinson Cancer Research Center and University of Washington Spin-off Biotech Startup which has been registered to CoMotion lab, UW. The mission of the company is to develop innovative immunotherapy technologies and products in the field of precision medicine, such as therapeutic cell products, diagnostic reagents, and recombinant pharmaceutical protein, to help cure serious human diseases, including cancer, autoimmune disease and virus-infection diseases.